Robert Dorsey, MD
Surgery · Poplar Bluff, MONPI 1013905520
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,829 of the $3,375 with a category attached, or 83.8%. 14 manufacturers reported payments, led by Convatec Inc. at 36.4% of the total. Reporting peaked in 2024 at $1,310 and has fallen 60.1% since, to $522 in 2025.
Across 147 payments — averaging $22.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$1K
- Smith+Nephew$845
- Organogenesis Inc.$510
- Paratek Pharmaceuticals, Inc.$392
- KCI USA, Inc.$96
- Mimedx Group, Inc.$76
- plus $228 from 8 others
Across 1 payment — averaging $1589.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Reapplix Inc.$2K
What the payments were for
- Travel & lodging$54616%
- Food & beverage$2,82984%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 16 | $1,227 |
| Smith+Nephew | 50 | $845 |
| Organogenesis Inc. | 24 | $510 |
| Paratek Pharmaceuticals, Inc. | 37 | $392 |
| KCI USA, Inc. | 4 | $96 |
| Mimedx Group, Inc. | 4 | $76 |
| Hartmann USA, Inc. | 4 | $62 |
| Reapplix Inc. | 1 | $40 |
| Tactile Systems Technology Inc | 2 | $33 |
| Solventum Corporation | 1 | $23 |
| CGG Medical Inc | 1 | $21 |
| Molnlycke Health Care US, LLC | 1 | $20 |
| Reprise Biomedical, Inc. | 1 | $18 |
| Kerecis Limited | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$916
- COLLAGENASE SANTYL$110
- PICO$109
How this compares
$3,375 in reported general payments places this provider in the 60th percentile of 612 surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 45 | $52,059 |
| Piperacillin-TazobactamPiperacillin Sodium/Tazobactam | 29 | $6,572 |
| Levofloxacin | 103 | $872 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 50 | $670 |
| Doxycycline Hyclate | 35 | $411 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 53 | $381 |
| Cephalexin | 17 | $162 |
| Tramadol Hcl | 18 | $100 |
| Fluconazole | 14 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $845 | $52,05945 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 612 surgery providers in Missouri.
Other surgery in Poplar Bluff
- James ScottSaint Louis$307K
- Omar GuerraSaint Louis$249K
- John TannColumbia$216K
- Mark DrakeSaint Louis$212K
- Adeel KhanSaint Louis$204K
- Michael AwadSaint Louis$176K
- Patricia HodginsFenton$145K
- Laurie PunchSaint Louis$141K
- Jeffrey BlatnikSaint Louis$134K
- Bradley MooreKansas City$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.